- Home
- PFBC vs CVAC Comparison
PFBC vs CVAC Comparison
Compare PFBC & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFBC
- CVAC
- Stock Information
- Founded
- PFBC 1991
- CVAC 2000
- Country
- PFBC United States
- CVAC Germany
- Employees
- PFBC N/A
- CVAC N/A
- Industry
- PFBC Major Banks
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- PFBC Finance
- CVAC Health Care
- Exchange
- PFBC Nasdaq
- CVAC Nasdaq
- Market Cap
- PFBC 1.1B
- CVAC 1.2B
- IPO Year
- PFBC 1998
- CVAC 2020
- Fundamental
- Price
- PFBC $93.21
- CVAC $5.36
- Analyst Decision
- PFBC Hold
- CVAC Hold
- Analyst Count
- PFBC 3
- CVAC 3
- Target Price
- PFBC $103.67
- CVAC $6.83
- AVG Volume (30 Days)
- PFBC 61.4K
- CVAC 473.0K
- Earning Date
- PFBC 10-20-2025
- CVAC 11-11-2025
- Dividend Yield
- PFBC 3.19%
- CVAC N/A
- EPS Growth
- PFBC N/A
- CVAC N/A
- EPS
- PFBC 9.51
- CVAC 1.01
- Revenue
- PFBC $267,978,999.00
- CVAC $599,540,810.00
- Revenue This Year
- PFBC $2.56
- CVAC N/A
- Revenue Next Year
- PFBC $3.42
- CVAC $24.04
- P/E Ratio
- PFBC $9.88
- CVAC $5.31
- Revenue Growth
- PFBC 1.62
- CVAC 675.15
- 52 Week Low
- PFBC $71.90
- CVAC $2.37
- 52 Week High
- PFBC $99.78
- CVAC $5.72
- Technical
- Relative Strength Index (RSI)
- PFBC 48.26
- CVAC 45.90
- Support Level
- PFBC $94.28
- CVAC $5.32
- Resistance Level
- PFBC $95.23
- CVAC $5.41
- Average True Range (ATR)
- PFBC 1.81
- CVAC 0.04
- MACD
- PFBC -0.22
- CVAC -0.01
- Stochastic Oscillator
- PFBC 11.21
- CVAC 40.00
About PFBC Preferred Bank
Preferred Bank is a commercial bank located in California. Its products and services are divided into Personal Banking, Business Banking, and Commercial Banking which includes Checking accounts, Savings accounts, CDs, Loans and Credit, Electronic banking, and Treasury Management. It provides personalized deposit services, real estate finance, commercial loans, and trade finance credit facilities to small and mid-sized businesses and their owners, entrepreneurs, real estate developers and investors, professionals, and high-net-worth individuals. The bank generates a majority of its revenue from Southern and Northern California and Flushing.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.